These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21416746)

  • 1. [Tramadol-induced hypoglycemia in a diabetic patient].
    Jonville-Bera A-; Marie A; Magba D; Gedon E; Autret-Leca E
    Therapie; 2010; 65(5):499-500. PubMed ID: 21416746
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tramadol-induced hypoglycemia. 2 cases].
    Grandvuillemin A; Jolimoy G; Authier F; Dautriche A; Duhoux F; Sgro C
    Presse Med; 2006 Dec; 35(12 Pt 1):1842-4. PubMed ID: 17159739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing mistakes in patient administration of glargine and lispro.
    Schutta MH
    Diabetes Care; 2002 Jun; 25(6):1098-9. PubMed ID: 12032124
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of insulin glargine during pregnancy in a type 1 diabetic woman.
    Devlin JT; Hothersall L; Wilkis JL
    Diabetes Care; 2002 Jun; 25(6):1095-6. PubMed ID: 12032121
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of adolescents with type 1 diabetes mellitus.
    Garg S; Chase HP
    J Pediatr Endocrinol Metab; 2004 May; 17(5):805-6. PubMed ID: 15237718
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of glargine insulin before and during pregnancy in a woman with type 1 diabetes and Addison's Disease.
    Dolci M; Mori M; Baccetti F
    Diabetes Care; 2005 Aug; 28(8):2084-5. PubMed ID: 16043769
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful treatment of insulin allergy in a 1-year-old infant with neonatal diabetes by lispro and glargine insulin.
    Kara C; Kutlu AO; Evliyaoglu O; Bilgili H; Yildirim N
    Diabetes Care; 2005 Apr; 28(4):983-4. PubMed ID: 15793215
    [No Abstract]   [Full Text] [Related]  

  • 8. Insulin glargine: commentary on the duration of action and lower risk of nocturnal hypoglycaemia in patients with diabetes.
    Rosenstock J; Owens D
    Expert Opin Pharmacother; 2004 Jan; 5(1):1-2; author reply 2-3. PubMed ID: 14680430
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative trial between insulin glargine and NPH insulin in children and adolescents with type 1 diabetes.
    Schober E; Schoenle E; Van Dyk J; Wernicke-Panten K;
    Diabetes Care; 2001 Nov; 24(11):2005-6. PubMed ID: 11679478
    [No Abstract]   [Full Text] [Related]  

  • 10. Basal insulin glargine vs prandial insulin lispro in type 2 diabetes.
    Oliveira JH; Kazda C; Simpson A; Jackson JA; Heine RJ
    Lancet; 2008 Aug; 372(9636):371-2; author reply 372. PubMed ID: 18675683
    [No Abstract]   [Full Text] [Related]  

  • 11. Insulin glargine: a new basal insulin analogue.
    Younis N; Soran H; Bowen-Jones D
    QJM; 2002 Nov; 95(11):757-61. PubMed ID: 12391389
    [No Abstract]   [Full Text] [Related]  

  • 12. Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.
    Rossetti P; Pampanelli S; Fanelli C; Porcellati F; Costa E; Torlone E; Scionti L; Bolli GB
    Diabetes Care; 2003 May; 26(5):1490-6. PubMed ID: 12716810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of mixing glargine and short-acting insulin analogs on glucose control.
    Kaplan W; Rodriguez LM; Smith OE; Haymond MW; Heptulla RA
    Diabetes Care; 2004 Nov; 27(11):2739-40. PubMed ID: 15505016
    [No Abstract]   [Full Text] [Related]  

  • 14. [Severe hypoglycemia following tramadol intake in a 79 year old non-diabetic patient].
    Kürten C; Tzvetkov M; Ellenrieder V; Schwörer H
    Dtsch Med Wochenschr; 2016 Sep; 141(20):1480-1482. PubMed ID: 27701696
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduction in short-acting insulin requirement accompanies improved glycemic control with basal insulin peglispro compared with insulin glargine in patients with type 1 diabetes.
    Rosenstock J; Blevins TC; Bergenstal RM; Morrow LA; Qu Y; Jacober SJ
    J Diabetes; 2016 Jan; 8(1):166-9. PubMed ID: 26278063
    [No Abstract]   [Full Text] [Related]  

  • 16. From the coalface: does glargine insulin improve hypoglycaemic episodes, glycaemic control or affect body mass in type 1 diabetic subjects who are attending a 'routine' diabetes clinic?
    Distiller LA; Joffe BI
    Diabetologia; 2006 Nov; 49(11):2793-4. PubMed ID: 17047914
    [No Abstract]   [Full Text] [Related]  

  • 17. Improvement of glycemic control without severe hypoglycemia in a type 1 diabetes patient undergoing hemodialysis after a change from insulin glargine to insulin degludec.
    Takahashi N; Tsujimoto T; Inoue K; Kishimoto M; Kajio H
    J Diabetes Investig; 2016 Sep; 7(5):805-6. PubMed ID: 27586093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin analogues.
    Marks J
    Postgrad Med; 2002 Nov; 112(5 Suppl Designer):8-12. PubMed ID: 19667599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes.
    Brunelle BL; Llewelyn J; Anderson JH; Gale EA; Koivisto VA
    Diabetes Care; 1998 Oct; 21(10):1726-31. PubMed ID: 9773738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glargine and lispro: two cases of mistaken identity.
    Adlersberg MA; Fernando S; Spollett GR; Inzucchi SE
    Diabetes Care; 2002 Feb; 25(2):404-5. PubMed ID: 11815523
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.